MEASUREAAVitHS

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Brief summary

This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.

Observational study

Status:
Recruiting
Conditions:
Non-Segmental Vitiligo (NSV)
Alopecia Areata
Hidradenitis Suppurativa
Enrollment:
2795 patients
Protocol ID:
H25-663
Observational model:
Case-Only
Time perspective:
Cross-Sectional

 

Eligibility criteria

Participant attributes:
Male and Female

Age:

12 Years and older.

Inclusion Criteria:

- Participants with Physician-confirmed diagnosis of non-segmental vitiligo (NSV),
moderate to severe Alopecia Areata (AA), or moderate to severe hidradenitis
suppurativa (HS)

- Participants Ability to understand study questionnaires, with caregiver support as
required for adolescents

Exclusion Criteria:

- Participating in interventional clinical trial(s) at time of study visit
(participation in another non-interventional study or registry does not exclude a
participant from this study)

- Unable or unwilling to comply with study requirements and PRO collection

All the cities where the clinical studies are located

More information about this study

clinicaltrials.gov